# Leonard Lauder

> Leonard Lauder is a startup investor at Alzheimer's Drug Discovery Foundation. See 0 investments, check sizes, portfolio. Updated Aug 2026.

- Type: Angel Investor
- Fund: [Alzheimer's Drug Discovery Foundation](https://shizune.co/investors/profile/alzheimers-drug-discovery-foundation)
- Last updated: Aug 2026

Leonard Lauder is a startup investor at Alzheimer's Drug Discovery Foundation. Leonard A. Lauder is Chairman Emeritus of The Estée Lauder Companies Inc. and is currently the senior member of its Board of Directors. Founded in 1946, the Company is one of the world's leading manufacturers and marketers of quality skin care, makeup, fragrance and hair care products, with annual sales of $10.97 billion. Its products are soldin over 150 countries and territories across more than 30 well-recognized brand names.A graduate of the University of Pennsylvania’s Wharton School, Mr. Lauder also studied at Columbia University’s Graduate School of Business and served as a lieutenant in the U.S. Navy. He formally joined Estée Lauder in 1958, when it had annual sales of $800,000. Mr. Lauder consistently developed and implemented innovative sales and marketing programs and increased the Company’s sales and profits. He created its first research and development laboratory and brought in professional management on every level. He also initiated The Estée Lauder Companies’ international expansion, which began in 1960 with the opening of the Estée Lauder account at Harrods in London.Mr. Lauder served as President of The Estée Lauder Companies from 1972 to 1995 and as Chief Executive Officer from 1982 to 1999. He added the title of Chairman in 1995 and served as Chairman of The Estée Lauder Companies through June 2009. Under his leadership, the Company launched many brands, including Aramis, Clinique, Lab Series and Origins. Beginning in the mid-1990s, the company also began expanding through acquisitions, including Aveda, Bobbi Brown, Jo Malone London, La Mer and M·A·C.In addition to his activities with The Estée Lauder Companies, Mr. Lauder is extremely involved in the worlds of education, art, politics and philanthropy. He is Emeritus Trustee of the University of Pennsylvania and a founding member of the Board of Governors of its Joseph H. Lauder Institute of Management and International Studies. Mr. Lauder became a Trustee of the Whitney Museum of American Art in New York City in 1977 and currently serves as its Chairman Emeritus. He is Co-Founder and Co-Chairman of the Alzheimer’s Drug Discovery Foundation; Co-Chairman of the Breast Cancer Research Foundation Board of Directors; a member of the Council on Foreign Relations; Chairman Emeritus and Lifetime Trustee of the Board of Directors of the Aspen Institute, as well as former Chairman of the Aspen Institute International Committee; and a member of the President’s Council of Memorial Sloan-Kettering Hospital. Mr. Lauder served on the Advisory Committee for Trade Negotiations under President Ronald Reagan. Among his honors, he has been named an Officier de la Légion d’Honneur by France and recognized by the United States Navy Supply Corps Foundation with its Distinguished Alumni Award. The Lauder Family received the esteemed 2011 Carnegie Medal of Philanthropy in recognition of its long-standing commitment to philanthropy and public service. Mr. Lauder was the 2013 recipient of the Palazzo Strozzi Renaissance Man of the Year Award, and most recently, he was named a 2014 Living Landmark by the New York Landmarks Conservancy.Mr. Lauder was married to Evelyn H. Lauder (Senior Corporate Vice President for The Estée Lauder Companies Inc.) from 1959 until she passed away in 2011. They had two sons together, William (Executive Chairman, The Estée Lauder Companies) and Gary (Managing Partner, Lauder Partners LLC), and five grandchildren.On January 1, 2015, Mr. Lauder married Judy Glickman Lauder, an internationally recognized philanthropist and photographer whose work is represented in over 300 public and private collections, including the J. Paul Getty Museum and the Whitney Museum of American Art.

## About Alzheimer's Drug Discovery Foundation

VC Fund · New York, United States

The Alzheimer’s Drug Discovery Foundation (ADDF) is the only public charity solely dedicated to finding effective drugs for Alzheimer’s disease. Our pioneering biomedical venture philanthropy approach allows us to invest in the most promising drug discovery and development programs around the world in both academic institutions andbiopharmaceutical companies. Since our founding in 1998, the ADDF has invested nearly $100 million to support over 500 programs across 18 countries.

5 contacts available at Alzheimer's Drug Discovery Foundation.

| Name | Title | Profile |
| --- | --- | --- |
| Howard Fillit | Co-Founder and Chief Science Officer | https://shizune.co/investors/profile/howard-fillit |
| Leonard Lauder | Co-Chairman & Co-Founder | https://shizune.co/investors/profile/leonard-lauder |
| Martin Tolar | Business Advisory Board & Scientific Review Board | https://shizune.co/investors/profile/martin-tolar |
| Meriel Owen | Director | https://shizune.co/investors/profile/meriel-owen-dfd5 |
| Ronald S. Lauder | Co-Chairman and Co-Founder | https://shizune.co/investors/profile/ronald-s-lauder |

## FAQ

### Is Shizune's investor data accurate?

Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.

# About Shizune
Shizune.co is an investor database. Core features:
- 48,091 startup investors (angels, VCs, accelerators, and others)
- Email, phone, LinkedIn (for intros), socials, and other contact data
- Updated daily from public funding news
- CSV and Excel export

The User can access the full database FOR FREE after signing up: shizune.co